NCT00834340View on ClinicalTrials.gov

Glimepiride 4 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Glimepiride 4 mg Tablets

1 x 4 mg, single-dose fasting

DRUG

AMARYL® 4 mg Tablets

1 x 4 mg, single-dose fasting

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834340 - Glimepiride 4 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter